Health Archive » May, 2009

Health - May, 2009

175 articles

• Centocor's Simponi May Cause Fatal Infections: FDA
• Unigen Founder Ordered To Testify In Seroctin IP Suit
• Investor's $70M Suit V. Abbott Sent To Arbitration
• Rescission Suit Against Blue Shield Dismissed
• FTC, Wholesalers Amend AndroGel Complaints
• Stiefel Hits KV With Patent Suit Over Acne Gel
• Inequitable Conduct Still A Thorny Issue
• Aventis To Pay $96M To End Medicaid Rebate Probe
• FTC Moves To Squash $3.1B CLS-Talecris Merger
• Merchant & Gould Nabs 5 IP Pros For New Wis. Office
• USPTO Grants Re-Exam Of Merck Singulair Patent
• $4.7B Express Scripts-NextRX Merger Accelerates
• New Lexapro Class Action Can't Tag Onto MDL
• J&J Seeks To Reclaim Schering's Arthritis Drug Rights
• Boehringer Loses Bid To Appeal Reps' FLSA Status
• Ex-Cardinal Health Officers Settle SEC Fraud Charge
• Centocor Patents Stand In Fight Over Abbott's Humira
• AstraZeneca Sued For $1.3B Over Failed Drug Deal
• 1 Type Of GE Ultrasound Infringes SonoSite IP: Court
• Failure To Show Injury Dooms ERISA Suit V. Medtronic
• 'I've Fallen And I Can't Get Up!' Verboten For Ads
• Whistleblower Claims Over Lipitor Marketing Tossed
• Most Claims Survive In Royalty Spat Over HPV Drug
• High Court To Hear Merck Bid In Vioxx Class Action
• SkinMedica Sues Histogen Over Anti-Aging Patent
• 1st Seroquel Trial Plaintiff Fails To Prove Causation
• Biovail, Melnyk Reach Proxy Deal Ahead Of Powwow
• Medtronic Trade Secrets Suit Against Nova Lives On
• Lead Plaintiff Chosen In Medtronic Securities Suit
• FTC Will Push To Block $3.1B CSL-Talecris Merger
• GSK Argues Outside Sales Exemption In OT Suit
• Cardiologist's IP Suit V. Medtronic Gets Go-Ahead
• NLRB Allows St. Barnabas Residents To Unionize
• FDA Puts The Kibosh On Distracting Drug Ads
• Ala. Scores $89M In Drug Co. Medicaid Fraud Case
• $350M United Healthcare ERISA Settlement Stalled
• Fed. Circ. Orders Transfer of Sanofi Patent Suit
• Teva Targets Amgen Over Kidney Drug
• DR Systems, ERAD Settle Medical Imaging Patent Spat
• HealthSouth Wins Ruling Over $376M Judgment
• Secrets Of Success For Today's Summer Associates
• Judge Finds No Direct Infringement In Strattera Suit
• Medtronic Updates Stent Report Targeting Abbott
• Changes To FCA Increase Contractor Liability
• Investor Suit Against Dendreon Can Proceed
• Doctor's Insider Trading Suit Moves Toward Trial
• Patent Damages Best Left To Courts: Chief Judge
• Johnson & Johnson Aims To Regain Remicade Rights
• Seroquel Docs Implicate AstraZeneca Execs: Attys
• Defendant In J&J Counterfeit Suit Agrees To Judgment
• Insurer Hit With Class Action Over Cancer Costs
• Cobalt Strikes Back At Pfizer In Lyrica Patent Spat
• Apotex Enjoined From Launching Generic Pulmicort
• MIT, E8 Sue Navigenics Over Genetic Testing Patent
• Insurer Off Hook For Qui Tam Suit V. Ill. Nursing Home
• Par Claims Rival Misled Patients With Nasal Spray
• Sanofi Uroxatral Claim Construction Gets Judge's Nod
• Solvay, Unimed Sued Again Over AndroGel Deals
• Bill Seeks ERISA Coverage For Second Opinions
• Medical Co. Asks Judge To Muzzle Greenberg Traurig
• Amended Complaint Merges Medicis Investors' Claims
• Apotex Antitrust Claims Tossed From Daiichi IP Spat
• Judge Blasts Plaintiffs' Lawyer In Guidant MDL
• EU Court Upholds Limits On Pharmacy Ownership
• Sens. Push To Bring Tobacco Under FDA Oversight
• Nurses Reach $7.2M Deal In Wage-Fixing Case
• $20M Suit Against Blue Cross NC Pared Down
• Fed. Circ. Nixes Autogenomics Patent Suit Appeal
• Fed Circ. Sets Product-By-Process Patent Restrictions
• Oxford Health Loses Bid to Toss Benefit Suit
• Onyx Sues Partner Bayer Over New Cancer Treatment
• Suit Over Alleged Egg-Sharing Tossed Once Again
• Guidant Sues Rival, Ex-Workers Over Exodus
• Abbott Loses Bid For Judgment In $200M Stent Case
• $52M Damages Pared In Siemens Scanner Patent Suit
• WellCare Pays $11M To Settle SEC Fraud Suit
• FDA Lovenox Ruling Key To Competition Claims: Judge
• High Court Won't Hear Baxter Mixed-Motive Bias Case
• Hospitals Seek Defense Costs For Kickback Suit
• DOJ, States Join Whistleblower Suits V. Wyeth
• 3rd Parties Again Denied Class Cert. In Neurontin Suit
• Bill Calls For Clear Labels For Health Insurance
• USPTO Rules On Stem Cell Patents In Biotech Battle
• The FTC, Reverse Payments In The Obama Era
• Genzyme Sues Lupin Over Generic Renvela Plans
• Conditional Cert. Granted In Suit V. Health System
• Pfizer To Pay $75M In Nigerian Meningitis Case
• Summary Judgment Denied In Humira Patent Case
• US Co-Owned Patent Not Immune To Suit: Judge
• Judge Tinkers With Class In Nurse Antitrust Case
• Pharma Group Takes Swipe At EU Antitrust Probe
• Lanwood V. Seeger: A Cautionary Tale
• Teva, Sun Still Free To Make Generic Protonix
• Teva, Zydus Reach Settlement Over Coreg Patents
• Medtronic Execs Shake Off Shareholder's Claims
• Fed. Circ. Upholds P&G's Actonel Patent
• AAI Calls For Hard Look At Benefits Cos.' Merger
• Bayer Wants $2M Back From Ex-CEO In ERISA Spat
• Myriad Gene Patents Invalid, Unconstitutional: ACLU
• Mylan Didn't Infringe Invalid Mirapex Patent: Judge
• FDA Warns Sanofi Over Taxotere Marketing Claims
• VPX Wants Muscle Drink On Shelves Pending Appeal
• Recruiters Can't Halt Unofficial H-1B Rule: Judge
• Connetics Shareholders Win Class Certification
• Expert Witness Can't Testify in Zyprexa MDL: Judge
• Sanofi-Aventis Suit Stayed For Genentech Petition
• Vt. High Court Says Pets Not Family In Eyes Of Law
• 8th Circ. Last Hope For Medtronic MDL Plaintiffs
• 2nd Circ. Asks NLRB To Rule On Conflicting Statutes
• Attorneys Seek About Half Of E-MedSoft.com Deal
• Parents Target Lilly's Strattera In Negligence Suit
• Wis. AG Seeks $212M Forfeiture From Pfizer Unit
• Materialise To Appeal Nobel's Noninfringement Win
• ERISA Preemption Denied In Calif. ER Coverage Suit
• Bavarian Nordic IP Suit Over Cancer Vaccine Lives
• Plaintiffs Lose Bid For Judgment In Vioxx ERISA MDL
• Ex-Enzo Biochem Honcho Wants $10M Under SOX
• AstraZeneca Asserts New Patent In Pulmicort Suit
• Plaintiffs Protest $45M Becton Dickinson Settlement
• 'Baseless' Shareholder Action V. Biovail Tossed
• Simbionix Wants McKool Smith Off Patent Suit
• Merck Seeks To Boot Fosamax Plaintiffs, Experts
• Reckitt Benckiser Sues Watson Again Over Mucinex
• Judge Holds Off On Class Cert. In Drug Price Suit
• US House Lawmakers Weigh Bill To Overturn Riegel
• Trojan Condom Maker Says Incentives Are Fair Game
• Novo Nordisk To Pay $18M In Oil-For-Food Cases
• Medtronic To Pay J&J $270M Over Stent Patent Fees
• Biomet Reaches Deals In 24 W.Va. Negligence Suits
• Plaintiffs Add Damages Claims To Bayer Aspirin Suit
• Texas Hang-Ups May Boost Patent Suits In Delaware
• 8 Simple Rules For A Successful Direct Exam
• Making The Most Of Rule Of Evidence 502
• Calif. Vioxx Users Denied Class Status
• FDA Calls For Black Box Warnings On AndroGel, Testim
• Riegel Preempts Conn. Defibrillator Suit: Court
• Are We Hiring A Justice Or Playing Politics?
• Thermo Fisher Sued Over LED Spectroscopy Patent
• Orion, Wockhardt Strike Deal Over Parkinson's Drugs
• Forest Loses Bid To Limit Liability In Citalopram IP Suit
• Testimony Tying Suicide, Pfizer Epilepsy Drug OK'd
• State Lawmakers Call For FTC To Probe CVS Caremark
• FDA Asks For $510M To Tighten Food, Drug Safety
• Hydroxycut Class Actions Filed In Mass., Ala.
• SC Wins Return Of Seroquel Suit To State Court
• Novartis Loses Bid To End Wyeth ReFacto Patent Suit
• DOJ Subpoenas J&J Unit In Reagents Antitrust Probe
• Biotech Co. May Face Ch. 7 Without DIP Loan
• Biosite Inc. Recalls Cardiac Marker Test
• 9th Circ. Seeks Clarity On Calif. Sales Reps' OT Status
• Preemption Pivotal To Medical Device Sector: Paper
• Wyeth Hits Sun, Caraco With False Advertising Suit
• GSK To Sell Wellbutrin In US To Biovail For $510M
• FDA Warns P&G Over Contamination Risk At Plant
• 3rd Circ. Remands AstraZeneca Preemption Case
• Covington Hires Food And Drug Co-Chair From FDA
• Lilly Loses Bid To Force Discovery In Zyprexa MDL
• NJ, Synthes Settle Over Financial Disclosures
• FDA Tells Baxter To Tone Down Tisseel Marketing
• Illumina Sues Affymetrix Over Genetic Tech Patent
• Warner Chilcott Sues Mylan Again Over Doryx ANDA
• Conn.'s Deposition Requests Limited In Zyprexa MDL
• Abbott Opens Fire On J&J Unit Over Humira Patent
• NYC To Get Data In Suit To Stop Insurance Merger
• Loss Causation Experts After Dura
• Sepracor Lied To USPTO In Lunesta Patent App: Suit
• What's Next For Stem Cells?
• Nonparties Can't Help Class In Sanofi Suit: Judge
• 2-Year Patent Extension For Levaquin Sticks
• Sequenom Faces Suit Over Mishandled Test Data
• GINA's Impact On Clinical Research Trials
• Wyeth Wants Howrey Nixed As Boston Sci Counsel
• Biovail, GSK Want Wellbutrin Antitrust Suit Tossed
• Applera Wins Fees In Calif. Appeal Over DNA Patent
• 7th Circ. Sends Product Liability Cases To Argentina